Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Receivables - Net: 2009-2025

Historic Receivables - Net for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $231.1 million.

  • Pediatrix Medical's Receivables - Net fell 8427.39% to $231.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $231.1 million, marking a year-over-year decrease of 8427.39%. This contributed to the annual value of $260.0 million for FY2024, which is 8114.94% down from last year.
  • Pediatrix Medical's Receivables - Net amounted to $231.1 million in Q3 2025, which was down 8427.39% from $239.0 million recorded in Q2 2025.
  • Pediatrix Medical's 5-year Receivables - Net high stood at $1.5 billion for Q4 2022, and its period low was $231.1 million during Q3 2025.
  • In the last 5 years, Pediatrix Medical's Receivables - Net had a median value of $1.4 billion in 2023 and averaged $1.2 billion.
  • As far as peak fluctuations go, Pediatrix Medical's Receivables - Net skyrocketed by 3095.77% in 2022, and later crashed by 8427.39% in 2025.
  • Over the past 5 years, Pediatrix Medical's Receivables - Net (Quarter) stood at $1.4 billion in 2021, then rose by 11.12% to $1.5 billion in 2022, then fell by 10.93% to $1.4 billion in 2023, then plummeted by 81.15% to $260.0 million in 2024, then decreased by 11.1% to $231.1 million in 2025.
  • Its last three reported values are $231.1 million in Q3 2025, $239.0 million for Q2 2025, and $242.5 million during Q1 2025.